The Pharma Career Ladder · The country manager · Step 3: Money, pricing and forecast · Lesson 16

The cost of complexity

Too many SKUs, too many promises

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

Nobody sets out to build a complicated business.

It happens one small yes at a time.

A new pack size because one hospital asked. A second strength because a competitor has one. A special term for one distributor, then another. A promise to a key account that only one person remembers.

Each decision makes sense on its own day.

Together they cost more than anyone planned. Every extra SKU needs registration, forecasting, stock, and time in the field. Every special term needs someone to track it. And the team's attention gets spread thinner every quarter.

In my experience, the signs show up before anyone names the problem. Forecasts get harder. Short-dated stock appears on small packs nobody watches. Reps carry lines they cannot explain.

So once a year I ask the team to list everything we carry and everything we have promised. For each one, one question: what does it add for patients and customers?

The ones that add little are retired properly. Customers are told early, the authority is informed, and patient supply is protected.

“Every SKU is a promise. Keep fewer, and keep them well.”
The cost of complexity: Too many SKUs, too many promises

Lesson 16 of 17 in Step 3: Money, pricing and forecast, with the full guide and a checklist for this week.

More lessons in step 3: Money, pricing and forecast

Money, pricing and forecast, in RepPharma

Targets split by rep, product and month

Yearly targets are split by rep, product and month, and sales credit can be moved between reps without changing the company total.

Distributor stock and sell-out

Distributor stock and pharmacy sell-out side by side, with short-expiry lots flagged up to 90 days ahead.

One system for the whole field force

Visits, plans, forecasts, samples, expenses, leaves and approvals, with role-based access from rep to country manager.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.